The Impact of Mitochondrial Dysfunction in human oocytes on Embryo quality and Conception rates in IVF patients with varying stages of Endometriosis

Endometriosis is a chronic, estrogen-dependent gynecological condition that is closely linked to infertility. Although significant progress has been made in assisted reproductive technologies (ART), including in vitro fertilization (IVF), women with endometriosis frequently encounter challenges such as poor oocyte quality, impaired embryo development, and lower pregnancy rates. Emerging evidence suggests that mitochondrial dysfunction, particularly through reduced ATP production and mitochondrial DNA (mtDNA) deletions, plays a critical role in the reproductive difficulties observed in these patients. Aim: The aim is to evaluate the impact of mitochondrial dysfunction on oocyte quality, embryo development, and IVF outcomes in women with endometriosis, comparing them with a control group of women without endometriosis. Methodology: A prospective cohort study was conducted over three years (2021-2024) at the Medical Health and Research Institute, involving 60 women aged 20-40 years. The cohort consisted of 42 women diagnosed with endometriosis (study group) and 42 women undergoing IVF treatment without endometriosis (control group). Mitochondrial function, including ATP content and mitochondrial DNA (mtDNA) integrity, was assessed in oocytes retrieved from both groups. The study compared the outcomes of oocyte maturation, fertilization rates, embryo development, implantation rates, and clinical pregnancy between the two groups.

The demographic and clinical characteristics of patients with endometriosis and controls revealed significant differences in age, body mass index (BMI), follicle-stimulating hormone (FSH) levels, and infertility duration. IVF outcomes showed no significant difference in clinical pregnancy rates (54.7% in endometriosis patients vs. 52.3% in controls), but endometriosis patients had slightly lower live birth rates (45.2% vs. 52.3%). Oocyte quality analysis indicated that endometriosis patients exhibited lower ATP content and mitochondrial number, particularly at the prophase I (PI) and metaphase I (MI) stages. Mitochondrial DNA deletions were found to have a significant negative impact on oocyte quality and IVF success, with all cycles involving oocytes with mtDNA deletions resulting in failure, including a biochemical pregnancy in a patient with moderate endometriosis.

Mitochondrial dysfunction, characterized by reduced ATP levels and mtDNA deletions, adversely impacts oocyte quality and IVF outcomes in women with endometriosis. These results highlight the importance of personalized IVF protocols that focus on mitochondrial health, potentially enhancing reproductive outcomes. Further research is needed to explore targeted interventions to minimize mitochondrial damage and improve ART success in this population.

Assaf L, Eid AA, Nassif J. Role of AMPK/mTOR, mitochondria, and ROS in the pathogenesis of endometriosis. Life sciences. 2022 Oct 1;306:120805. Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertility and sterility. 2012 Sep 1;98(3):511-9. Bhurke AV, Das Mahapatra P, Balakrishnan S, Khan SA, et al. Clinical characteristics and surgical management of endometriosis‐associated infertility: A multicenter prospective cohort study. Int J Gynaecol Obstet. 2022 Oct;159(1):86-96. Cacciottola L, Donnez J, Dolmans MM. Can endometriosis-related oxidative stress pave the way for new treatment targets? Int. J. Mol. Sci. 2021 Jul 1;22(13):7138. Chapron C, Marcellin L, Borghese B, et al. Rethinking mechanisms, diagnosis and management of endometriosis. Nature Reviews Endocrinology. 2019 Nov;15(11):666-82. Cecchino GN, Seli E, da Motta EL, et al. The role of mitochondrial activity in female fertility and assisted reproductive technologies: overview and current insights. Reproductive biomedicine online. 2018 Jun 1;36(6):686-97. Demain LA, Conway GS, Newman WG. Genetics of mitochondrial dysfunction and infertility. Clin Genet 2017: 91: 199–207. Ferrero S, Anserini P, Remorgida V, et al. Body mass index in endometriosis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2005 Jul 1;121(1):94-8. Giudice LC, Kao LC. Theories of pathogenesis. Lancet. 2004;364:1789-99. Giudice LC. Clinical practice: endometriosis. The N Engl J Med. 2010 June 24; 362(25): 2389–2398. Hamdan M, Dunselman G, Li TC, et al. The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis. Human reproduction update. 2015 Nov 1;21(6):809-25. Hsu AL, Townsend PM, Oehninger S, et al. Endometriosis may be associated with mitochondrial dysfunction in cumulus cells from subjects undergoing in vitro fertilization-intracytoplasmic sperm injection, as reflected by decreased adenosine triphosphate production. Fertility and Sterility. 2015 Feb 1;103(2):347-52. Jenabi E, Khazaei S, Veisani Y. The association between body mass index and the risk of endometriosis: a meta-analysis. Journal of Endometriosis and Pelvic Pain Disorders. 2019 Jun;11(2):55-61. Kirillova A, Smitz JE, Sukhikh GT, et al. The role of mitochondria in oocyte maturation. Cells. 2021 Sep 19;10(9):2484. Latif S, Saridogan E. Endometriosis, Oocyte, and Embryo Quality.J. Clin. Med. 2023, 12, 4186 Macer ML, Taylor HS. Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet Gynecol Clin North Am. 2012 December ; 39(4): 535–549. Máté G, Bernstein LR, Török AL. Endometriosis is a cause of infertility. Does reactive oxygen damage to gametes and embryos play a key role in the pathogenesis of infertility caused by endometriosis?. Frontiers in endocrinology. 2018 Nov 29;9:725. Nisenblat V, Bossuyt PM, Shaikh R, et al. Cochrane Gynaecology and Fertility Group. Blood biomarkers for the non‐invasive diagnosis of endometriosis. Cochrane Database Syst Rev 2016 May 1;2016(5):CD012179. Somigliana E, Berlanda N, Benaglia L, et al. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications. Fertility and sterility. 2012 Dec 1;98(6):1531-8. Somigliana E, Infantino M, Benedetti F, et al. The presence of ovarian endometriomas is associated with a reduced responsiveness to gonadotropins. Fertility and sterility. 2006 Jul 1;86(1):192-6. Torre SD, Benedusi V, Fontana R, et al. Energy metabolism and fertility—a balance preserved for female health. Nat. Rev. Endocrinol. 2014 Jan;10(1):13-23. Uncu G, Kasapoglu I, Ozerkan K, et al. Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve. Human reproduction. 2013 Aug 1;28(8):2140-5. Van Blerkom J. Mitochondrial function in the human oocyte and embryo and their role in developmental competence. Mitochondrion. 2011 Sep 1;11(5):797-813. Wallace DC. Mitochondrial DNA mutations in disease and aging. Environmental and molecular mutagenesis. 2010 Jun;51(5):440-50. Zhang D, Keilty D, Zhang ZF, Chian RC. Mitochondria in oocyte aging: current understanding. Facts Views Vis Obgyn, 2017, 9 (1): 29-38 Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020 Mar 26;382(13):1244-1256. Downloads Published How to Cite Issue Section License Copyright (c) 2025 American Journal of Medical and Clinical Research & Reviews This work is licensed under a Creative Commons Attribution 4.0 International License.